Burden of Cerebrovascular Diseases (Stroke) in Serbia

  • T. Pekmezovic
  • H. Vlajinac
  • S. Sipetic-Grujicic
  • N. Kocev
  • D. K. Tepavcevic
  • L. B. Bumbasirevic
Reference work entry


The purpose of the study was to provide a comprehensive review of the most important features regarding burden of cerebrovascular disease (i.e., stroke) in Serbia.

In Serbia, stroke is the leading cause of mortality in females (20.8% of all deaths) and the second cause in males (15.5%). The crude mortality rate from stroke in Serbia in 2000 was 248.8/100,000, and age-adjusted rate 122.6/100,000 (using Segi’s world standard population), while in the Belgrade population (period of observation: 1989–2003), the average standardized mortality rates (using Segi’s world standard population) for all stroke subtypes were 90.8/100,000 overall, 98.0/100,000 for men and 82.4/100,000 for women. The average standardized stroke mortality rates in Belgrade changed in the period 1989–2003 for both genders, the highest values being registered in the period 1994–1998 and the lowest in the period 1989–1993.

The burden of cerebrovascular disease in Serbia without Kosovo and Metohia in 2000, expressed in terms of as DALY was 65,795 in men and 70,295 in women (136,090 DALY for the total population). Stroke is the second leading cause of DALY for males, after IHD, and the leading cause for females. In Serbia 2000, YLL rates per 1,000 for stroke were lower in males (15.6/1,000) than in females (16.7/1,000). Moreover, in males stroke was the second leading single cause of premature YLL (13% of total YLL), while in females it ranked first (18% of total YLL). Rates of YLD per 1,000 were 2.3 for males and 1.4 for females. Hypertension as one of the most important risk factors for stroke was responsible for 13.3% of the total YLL in Serbia 2,000 in females and 9.7% in males. The proportion of total DALY calculated for stroke due to hypertension was higher for females (48.65%) than for males (40.51%).

In conclusion, the important findings obtained in the SBDS should be used as a guide for implementing preventive strategies, as well as for evaluating the scope of future gains obtained by reducing exposure to known risk factors for cerebrovascular disease.


Ischemic Stroke Physical Inactivity Stroke Subtype Stroke Incidence High Blood Cholesterol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:


 computed tomography


cerebrovascular diseases


disability adjusted life years


International Classification of Diseases


 intracerebral hemorrhage


ischemic heart disease


Monitoring of Trends and Determinants in Cardiovascular Disease


 magnetic resonance imaging


 subarachnoid hemorrhage


Serbian Burden of Disease Study


years lived with disability


years of life lost


World Health Organization


  1. Adanja B, Gledovic Z, Pekmezovic T, Vlajinac H, Jarebinski M, Zivaljevic V, Pavlovic M. (2000). Dig Liver Dis. 32: 386–391.PubMedCrossRefGoogle Scholar
  2. American Hear Association. (2008). Heart Disease and Stroke Statistics. 2008 Update At-a-Glance.Google Scholar
  3. Atanackovic Markovic Z, Bjegovic V, Jankovic S, Kocev N, Laaser U, Marinkovic J, Markovic Denic Lj, Pejin Stokic Lj, Penev G, Stanisavljevic D, Santric Milicevic M, Saulic A, Sipetic Grujicic S, Terzic Supic Z, Vlajinac H. (2003). The Burden of Disease and Injury in Serbia. Ministry of Health of Republic of Serbia, Belgrade.Google Scholar
  4. Avendano M, Kunst AE, van Lenthe F, Bos V, Costa G, Valkonen T, Cardano M, Harding S, Borgan JK, Glickman M, Reid A, Mackenbach JP. (2005). Am J Epidemiol. 161: 52–61.PubMedCrossRefGoogle Scholar
  5. Bevan G, Hollinghurst S, Raftery J, Gold L, Stevens A, Smithies A, Spurgeon R, Bowie C. (1998). The South and West DALYs Project: Developing a powerful tool for health care planning. Somerset Health Authority, Wellsprings Road, Taunton, Somerset.Google Scholar
  6. Cayuela A, Rodriguez S, Iglesias P, Lapetra J, Gil-Pelralta A. (2002). Neuroepidemiology. 21: 142–147.PubMedCrossRefGoogle Scholar
  7. Department of Human Services. (1999). The Victorian Burden of Disease Study: Mortality. Public Health and Development Division, Department of Human Services, Melbourne.Google Scholar
  8. Feigin VL, Lawes CMM, Bennett DA, Anderson CS. (2003). Lancet Neurol. 2: 43–53.PubMedCrossRefGoogle Scholar
  9. Francescutti C, Mariotti S, Simon G, D’errigo P, Di bidino R. (2005). Disabil Rehabil. 27: (5)229–240.PubMedCrossRefGoogle Scholar
  10. Institute of Public Health of Serbia. (2001). 2000 Population Health Survey in Serbia. Ministry of Health, Republic of Serbia, Belgrade.Google Scholar
  11. Jakovljevic D, Sarti C, Silvenius J, Torppa J, Mahonen M, Immonen-Raiha P, Kaarsalo E, Alhainen H, Kuulasmaa K, Tuomilehto J, Puska P, Salomaa V. (2001). Stroke. 32: 1492–1498.PubMedGoogle Scholar
  12. Jankovic S, Vlajinac H, Bjegovic V, Marinkovic J, Sipetic-Grujicic S, Markovic-Denic LJ, Kocev N, Santric-Milicevic M, Terzic-Supic Z, Maksimovic N, Laaser U. (2007). Eur J Publ Health. 17: 80–85.CrossRefGoogle Scholar
  13. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. (2006). Lancet. 367: 1747–1757.PubMedCrossRefGoogle Scholar
  14. Mariotti S, D’Errigo P, Mastroeni S, Freeman K. (2003). Eur J Epidemiol. 18: 513–521.PubMedCrossRefGoogle Scholar
  15. Mathers C, Stein C, Ma Fat D, Rao C, Inoue M, Tomijima N, Bernard C, Lopez A, Murray C. (2002). Global Burden of Disease 2000: Version 2 Methods and Results. GPE Discussion Paper No. 50. World Health Organization, Geneva.Google Scholar
  16. Mathers CD, Theo Vos E, Stevenson CE, Begg SJ. (2000). Med J Aust. 172: 592–596.PubMedGoogle Scholar
  17. Mathers CD, Theo Vos E, Stevenson CE, Begg SJ. (2001). Bull World Health Organ. 79: 1076–1084.PubMedGoogle Scholar
  18. Melse JM, Essink-Bot ML, Kramers PGN, Hoeymans N, on behalf of the Dutch Burden of Disease Group. (2000). Am J Publ Health. 90: 1241–1247.CrossRefGoogle Scholar
  19. Murray CJL, Lopez AD, (eds.) (1996). The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injures and risk factors in 1990 and projected to 2020. In: Global Burden of Disease and Injury Series. Harvard University Press, Cambridge.Google Scholar
  20. Murray CJL, Lopez AD. (1997a). Lancet. 349: 1498–1504.PubMedCrossRefGoogle Scholar
  21. Murray CJL, Lopez AD. (1997b). Lancet. 349: 1269–1276.PubMedCrossRefGoogle Scholar
  22. Murray CJL, Lopez AD. (1997c). Lancet. 349: 1436–1442.PubMedCrossRefGoogle Scholar
  23. Murray CJL, Lopez AD, Mathers CD, Stein C. (2001). The Global Burden of Disease 2000 project: aims, methods and data sources. World Health Organization, Geneva. Available on the worldwide web at
  24. Pajunen P, Paakkonen R, Hamalainen H, Keskimäki I, Laatikainen T, Niemi M, Rintanen H, Salomaa V. (2005). Stroke. 36: 244–248.PubMedCrossRefGoogle Scholar
  25. Pekmezovic T, Kisic Tepavcevic D, Jarebinski M, Kostic M, Bumbasirevic Lj. (2007). Cerebrovasc Dis. 24: 191–195.PubMedCrossRefGoogle Scholar
  26. Pekmezovic T, Kisic Tepavcevic D, Jarebinski M, Kostic M, Bumbasirevic Lj. (2008). Clin Neurol Neurosurg. 110: 51–57.PubMedCrossRefGoogle Scholar
  27. Peltonen M, Asplund K. (1996). Stroke. 27: 1981–1985.PubMedGoogle Scholar
  28. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O’Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y. for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.(2007). Circulation. 115: e69–e171.PubMedCrossRefGoogle Scholar
  29. Sarti C, Rastenyte D, Cepatis Z, Tuomilehto J. (2000). Stroke. 31: 1588–1601.PubMedGoogle Scholar
  30. Stegmayr B, Vinogradova T, Malyutina S, Peltonen M, Nikitin Y, Asplund K. (2000). Stroke. 31: 2–8.PubMedGoogle Scholar
  31. Sturgeon JD, Folsom AR. (2006). Neuroepidemiology. 28: 39–45.PubMedCrossRefGoogle Scholar
  32. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M. (1995). Stroke. 26: 361–367.PubMedGoogle Scholar
  33. Thorvaldsen P, Kuulasmaa K, Rajakangas AM, Rastenyte D, Sarti C, Wilhelmsen L. (1997). Stroke. 28: 500–506.PubMedGoogle Scholar
  34. Tosic O. (1992). Lancet. 340: 295–296.CrossRefGoogle Scholar
  35. Truelsen T, Piechowski-Jozwiak B, Bonita R, Mathers C, Bogousslavsky J, Boysen G. (2006). Eur J Neurol. 13: 581–598.PubMedCrossRefGoogle Scholar
  36. Vlajinac H, Marinkovic J, Kocev N, Adanja B, Pekmezovic T, Sipetic S, Jovanovic D. (1997). J Epidemiol Commun Health. 51: 172–174.CrossRefGoogle Scholar
  37. Vlajinac H, Marinkovic J, Kocev N, Adanja B, Sipetic S, Pekmezovic T, Zivaljevic V. (2000). Srp Arh Celok Lek. 128(9–10): 309–315.PubMedGoogle Scholar
  38. Vlajinac H, Marinkovic J, Kocev N, Sipetic S, Bjegovic V, Jankovic S, Stanisavljevic D, Markovic-Denic Lj, Maksimovic J. (2008). Public Health. 122: 277–284.PubMedCrossRefGoogle Scholar
  39. Vlajinac H, Sipetc S, Saulic A, Atanackovic Z, Marinkovic J, Bjegovic V. (2006). Eur J Cadiovasc Prev Rehabil. 13: 753–759.CrossRefGoogle Scholar
  40. World Health Organization. (1997). World Health Report 1997. Conquering Suffering, Enriching Humanity. World Health Organization, Geneva.Google Scholar
  41. World Health Organization. (2004). Global burden of stroke. In: Atlas of Heart Disease and Stroke. World Health Organization, Geneva, pp. 50.Google Scholar
  42. World Health Organization. (2006). Neurological Disorders: Public Health Challenges. World Health Organization, Geneva.Google Scholar

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • T. Pekmezovic
  • H. Vlajinac
  • S. Sipetic-Grujicic
  • N. Kocev
  • D. K. Tepavcevic
  • L. B. Bumbasirevic

There are no affiliations available

Personalised recommendations